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Abstract Antimicrobial stewardship teams have been shown
to increase appropriate empirical antibiotic therapy and reduce
medical errors and costs in targeted populations, but the effect in
non-targeted populations is still unclear. The aim of this study
was to determine the prevalence of inappropriate antibiotic use
in a large university hospital and identify areas in which anti-
microbial stewardship will be the most effective. In a point
prevalence survey we assessed the appropriateness of antibiotic
therapy using an electronic surveillance system in combination
with a standardized method for duration of therapy, dosage,
dosage interval, route of administration, and choice of antibiotic
drug. Patients using at least one antibiotic drug were included.
Among 996 patients admitted in the surveyed wards, 337 pa-
tients (33.8 %) used one or more antibiotic drugs. Two hundred
and twenty-one patients (22.2 %) used antibiotic medication
therapeutically, with a total of 307 antibiotic prescriptions. An-
tibiotic therapy was deemed inappropriate in 90 (29.3 %) of
these prescribed antibiotics, with an unjustified prescription as
the most common reason for an inappropriate prescription. Use
of fluoroquinolones and amoxicillin/clavulanic acid and a pre-
sumed diagnosis of fever of unknown origin, urinary tract in-
fection, and respiratory tract infection were associated with in-
appropriate antibiotic therapy. Our study provides insight into
the (in)appropriateness of antibiotic prescriptions in a tertiary
care center in the Netherlands and identifies areas for improve-
ment. The use of an electronic surveillance system for this point
prevalence study is easy and may serve as a baseline measure-
ment for the future effect of antibiotic stewardship.
Introduction
Antibiotics are an indispensable part of modern medicine.
However, as with all drugs, antibiotics may have adverse ef-
fects and medication errors can occur in prescribing. Another
untoward effect of antibiotics is the selection of antibiotic-
resistant bacteria. In 2007, more than 8,000 excess deaths in
Europe were associated with bloodstream infections caused
by methicillin-resistant Staphylococcus aureus (MRSA) and
third-generation cephalosporin-resistant Escherichia coli [1].
This mortality is only a fraction of the total burden of disease
associated with antibiotic resistance [1]. The U.S. Centers for
Disease Control and Prevention (CDC) estimated that each
year at least 2 million people in the USA acquire infections
with antibiotic-resistant bacteria, with at least 23.000 deaths as
a direct result of these infections [2]. Although in the Nether-
lands antimicrobial resistance is low compared to other coun-
tries [3], antimicrobial resistance here is also increasing [4].
A clear relationship has been found between the percentage
of resistant strains and antimicrobial use [5]. In addition, only
around 60 % of empirically started antibiotics are considered
appropriate [6–8]. Finding a balance between adequate anti-
biotic use for the individual patient, avoidance of selection of
antibiotic resistance, and medication errors is the key role of
antibiotic stewardship teams (ASTs) [9]. ASTs have been
shown to increase appropriate empirical antibiotic therapy
and reduce medical errors and costs [5, 10, 11]. Moreover,
by narrowing down earlier broad-spectrum treatment, the de-
velopment of antimicrobial resistance will decrease [5, 11]. In
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a hospital-wide rollout of antimicrobial stewardship, AST in-
tervention was associated with a large reduction in targeted
antimicrobial utilization among patients receiving at least
3 days of antimicrobial therapy, but no significant change
was observed hospital-wide [12].
The aim of this study was to determine the prevalence of
inappropriate antibiotic use and to identify the areas in which
ASTs can have an important impact hospital-wide.
Materials and methods
Setting
The Erasmus MC, University Medical Center Rotterdam is a
1,320-bed tertiary care center in Rotterdam with all medical
specialties available. In 2012, there were 41,773 admissions
and 286,155 bed days.
Cross-sectional point prevalence survey
The point prevalence survey of antimicrobial use was per-
formed on May 4th and May 16th 2013. Patients were select-
ed with E-Surveillance, an electronic surveillance system,
which has been operational in our hospital since 2011 [13,
14]. Originally, it was developed as a tool to automatically
select patients suspected of having hospital-acquired infec-
tions from a hospital-wide point prevalence population. In this
system, patient census data, antibiotic prescriptions, individu-
al antibiotic treatment, infectious disease consultancy reports,
laboratory data, microbiological results, vital signs, surgical
reports, and radiology reports are integrated. We used E-
Surveillance to execute a set of algorithms designed for this
study. First, the point prevalence population was automatical-
ly created. The study population consisted of all patients in all
clinical departments of the Erasmus MC [including a 32-bed
general intensive care unit (ICU)], with the exception of the
cardiothoracic ICU (18 beds), pediatric (200 beds), and psy-
chiatric wards (77 beds). Then, all patients using at least one
antibacterial for systemic use (ATC code starting with J01) on
May 4th or May 16th 2013 were marked, with the exception
of those patients that received their antibacterial prophylacti-
cally. An algorithm differentiated between therapeutic and
prophylactic use of the antibacterial based on our hospital’s
antibiotic policy. The following antibiotic drugs were defined
as prophylaxis and excluded by the E-Surveillance system:
cotrimoxazole at a dose of 480 mg, amoxicillin/clavulanic
acid given once, and cefazolin started preoperatively, intraop-
eratively, or in a postoperative period without another clear
indication. Antibiotics given regarding a prophylactic proto-
col, such as selective decontamination of the digestive tract,
antibiotics for patients with neutropenia, chronic obstructive
pulmonary disease (COPD), and feneticillin within a period of
2 years after splenectomy were also defined as prophylaxis.
Review of the antibiotic policy
Antibiotic drugs were also considered to be prophylactic if
they were recorded as such in patient progress notes. Relevant
data elements, such as age, sex, ward, and prescribed antibi-
otic(s) were retrieved from the E-Surveillance database. The
appropriateness of antibiotic therapy was determined for each
individual patient by both a clinical microbiologist and an
infectious disease consultant, using the standardized method
developed by Gyssens et al. [15]. Infection information from
the admission day until the prevalence day could be used to
assess the appropriateness of antibiotic therapy. Discrepancies
were discussed by the reviewers until consensus was reached.
Relevant parameters associated with antibiotic use were eval-
uated and the following classifications were used: appropriate
prescription, inappropriate prescription due to incorrect use,
incorrect choice or unjustified prescription, and insufficient
records for categorization. To evaluate the different relevant
parameters a flowchart was used by the reviewers for each
prescription, which resulted in classification of the prescrip-
tion into one of the possible categories shown in Table 1.
Antibiotic drug prescriptions could be placed in more than
one category if they were inappropriate for more than one
reason. All data were reviewed in E-Surveillance and, when
indicated, by chart review.
Prescribing therapeutic antibiotics was considered justified
for an infection that was either community-acquired or noso-
comial. A community-acquired infection was defined as doc-
umented or suspected infection within 48 h after admission
with fever (>38 °C) and/or elevated infection parameters (C-
reactive protein>10 mg/l, white cell count>11×109/l, or
erythrocyte sedimentation rate>20 mm/h) A nosocomial in-
fection was defined as infection meeting the CDC criteria and
occurring at least 48 h after admission.
The definition of appropriateness of antibiotic therapy was
based on the current local antimicrobial treatment guidelines,
which is in line with the national guidelines (http://www.
swabid.nl) and available microbiological results. The
antibiotic prescription was defined as inappropriate due to
unjustified prescription, when the use of an antibiotic was
not indicated because no infection was present. The
antibiotic drug prescription was also considered to be
inappropriate when the administered antibiotic drug was not
in line with the antibiotic guidelines, in case of allergy to the
prescribed antibiotic drug, or when a more effective, less
toxic, less expensive, and/or less broad-spectrum alternative
agent was available. Additionally, antibiotic drug prescription
was considered inappropriate in case of incorrect duration,
incorrect dosage, incorrect dosage interval, and/or incorrect
route of administration (Table 1). For an incorrect dosage,
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kidney and liver function were taken into account, as well as
the (available) antibiotic concentration in blood. The route of
antibiotic administration was considered incorrect when a pa-
tient was able to switch from intravenous (iv) to oral antibiotic
drugs when iv drugs had been given for 48 h, the signs and
symptoms of infection had improved, and an oral alternative
was available. Criteria that needed to be fulfilled were hemo-
dynamically stable; afebrile (i.e., temperature <38 °C for 24 h)
; diagnosis and/or pathogen known or highly probable; oral
intake possible; absence of factors interfering with drug re-
sorption and/or bioavailability; no contraindications for oral
antibiotics; and no significant interaction with other
medication.
Results
Antibiotic use and demographics
At the start of the survey, a total of 996 patients were admitted
on the included wards, of which 337 patients (33.8 %) were
using one or more antibiotic drugs. Antibiotic drugs were used
prophylactically in 116 patients; these patients were excluded
from the analysis. Two hundred and twenty-one patients
(22.2 %) used antibiotic medication therapeutically, with a
total of 307 antibiotic prescriptions. The median age of pa-
tients receiving antibiotic therapy was 62.6 years and 42 %
was female. In nearly half of the patients (45.3 %), a clinical
microbiologist or infectious diseases specialist was consulted.
Twenty patients were admitted on both point prevalence dates.
These patients used a total of 64 antibiotic drugs. On both
days, 15 of these antibiotics were still prescribed for the same
diagnosis. Most patients (68.3 %; 151/221) were treated with
one antibiotic drug, 57 patients (25.8 %) were treated with
two, and 13 (5.9 %) were treated with three or more antibiotic
drugs. Combinations of beta-lactam antibiotics plus or minus
beta-lactamase inhibitors were the most commonly prescribed
antibiotic class, followed by fluoroquinolones.
Appropriateness of antibiotic therapy
In total, 90 (29.3 %) of the 307 prescribed antibiotics were
classified as inappropriate antimicrobial drug therapy
(Table 1). More specifically, for 48 (15.6 %) prescriptions
there was no indication for antimicrobial therapy. Twenty-
five (8.1 %) prescriptions were an incorrect choice of antibi-
otic drug, for which a more effective, a less toxic, or a less
expensive alternative agent was available. Interestingly, in
nearly 36 % of the incorrectly chosen antibiotics, therapy
could have been narrowed down. Twenty-one (6.8 %) of the
prescribed antibiotic drugs were used incorrectly, mostly due
to an incorrect duration of therapy or an improper dosage
interval (Table 1).
Appropriateness of antibiotic therapy according
to antibiotic class, diagnosis, and ward
The rate of inappropriate antibiotic therapy varied from nearly
50 % for broad-spectrum antibiotic drugs to 10 % for narrow-
spectrum penicillins (Table 2). Antibiotic drugs used as em-
pirical therapy in our hospital, such as amoxicillin/clavulanic
acid and second-generation cephalosporins, had a higher rate
of inappropriate prescriptions than drugs that are more often
used in targeted therapy, such as glycopeptides and third-
Table 1 Categories evaluation of the appropriateness of antimicrobial drug therapy (ADT)
Categories Absolute
frequency
Percentage of total
number of prescriptions
I. Appropriate ADT 199 64.8
II. Inappropriate ADT, due to incorrect use: 21a 6.8
a. Improper duration 10 3.3
b. Improper route 6 2.0
c. Improper dosage interval 10 3.3
d. Improper dosage 8 2.6
III. Inappropriate ADT, due to an incorrect choice: 25a 8.1
a. Allergy to the prescribed antibiotic drug 0 0
b. Less broad-spectrum alternative agent 9 2.9
c. Less expensive alternative agent 7 2.3
d. Less toxic alternative agent 4 1.3
e. More effective alternative agent 15 4.9
IV. Inappropriate ADT, due to unjustified prescription: use of any antimicrobial is not indicated 48 15.6
V. Insufficient information 18 5.9
a Four antibiotic prescriptions were inappropriate due to incorrect use and choice
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generation cephalosporins. Antibiotic therapy prescribed for
respiratory tract infections (30.6 % of the total prescriptions)
was inappropriate in 38 % and for urinary tract infections
(20 % of the total prescriptions) in 45 % (Table 3). Most
antibiotic drugs were prescribed on only three wards: lung
diseases (18.6 %), surgery (17.3 %), and internal medicine
(14.7 %). Of all the medical specializations, neurosurgery
has the highest percentage of inappropriate antibiotic drug
therapy (44 %) (Table 4).
Discussion
In our tertiary care hospital, antibiotic drugs are used in 33.8 %
of the adult patients in general wards and 22.2 % is used ther-
apeutically. Of the patients prescribed antibiotics therapeutical-
ly, 90 (29.3 %) antibiotic prescriptions were inappropriate. The
highest percentage of inappropriately prescribed antibiotic
drugs was due to unjustified use, i.e., no antibiotic use was
deemed indicated. Improper dosing intervals and incorrect du-
ration were also commonly found, as well as prescription of an
antibiotic drug when a more effective alternative was available.
Urinary tract infection and respiratory tract infection were the
infections with the highest inappropriate antimicrobial drug
therapy. Our data offer areas of possible intervention by antimi-
crobial stewardship. In the future, repeated audits of the appro-
priateness of antimicrobial therapy will give insight into the
effectiveness of interventions aimed at improving antibiotic
drug use and, thus, the effect of ASTs.
Point prevalence surveys are useful tools to assess appro-
priate antibiotic use [7]. However, the required time invest-
ment and limited human resources can constitute a barrier to
perform such surveys. The time investment depends on the
size of the hospital, the kind of patients, the experience of the
reviewer, and a possible combination with other surveys, such
as point prevalence studies of infections. The time needed to
perform these surveys has been reported to be 10–20 min per
patient (personal communication with dr. P.R. Ingram [16]
and I. Willemsen [7]). Our study is, to our knowledge, the first
to use a computer-based surveillance system to estimate the
point prevalence of antibiotic use. With the use of our elec-
tronic surveillance system, with automatic selection of pa-
tients and extraction of data needed, it took us 5–10 min per
patient. Using E-Surveillance, we could determine the
Table 2 Appropriateness of antibiotic prescriptions according to the class of antibiotica
Antimicrobial agent Number of
prescriptions
(% of total)
Number of inappropriate
prescriptions
Proportion of inappropriate
prescriptions
(95 % confidence interval)
ORb for inappropriate
prescriptions
(95 % confidence interval)
Fluoroquinolones 37 (12.1) 18 0.49 (0.33–0.64) Reference
Amoxicillin/clavulanic acid 34 (11.1) 15 0.44 (0.29–0.61) 0.88 (0.34–2.29)
Meropenem 28 (9.1) 5 0.18 (0.08–0.36) 0.24 (0.07–0.77)
Cephalosporins, second generation 27 (8.8) 10 0.37 (0.22–0.56) 0.63 (0.22–1.74)
Piperacillin/tazobactam 26 (8.5) 8 0.31 (0.17–0.50) 0.50 (0.17–1.46)
Glycopeptides 22 (7.2) 1 0.05 (0.01–0.22) 0.05 (0.01–0.39)
Narrow-spectrum penicillinc 19 (6.2) 2 0.11 (0.03–0.31) 0.12 (0.02–0.59)
Penicillins with extended spectrumd 18 (5.9) 3 0.17 (0.06–0.39) 0.21 (0.05–0.88)
Macrolides 16 (5.2) 6 0.38 (0.18–0.61) 0.75 (0.22–2.60)
Cephalosporins, third generation 15 (4.9) 2 0.13 (0.04–0.38) 0.17 (0.03–0.85)
Metronidazole 12 (3.9) 2 0.17 (0.05–0.45) 0.20 (0.04–1.04)
Aminoglycosides 12 (3.9) 2 0.17 (0.05–0.45) 0.25 (0.05–1.34)
Polymyxinse 10 (3.3) 4 0.40 (0.17–0.69) 1.00 (0.22–4.63)
Clindamycin 9 (2.9) 1 0.11 (0.02–0.44) 0.13 (0.01–1.11)
Trimethoprim/sulfonamide 9 (2.9) 6 0.67 (0.35–0.88) 2.00 (0.43–9.26)
Otherf 13 (4.2) 5 0.38 (0.18–0.64) 0.83 (0.22–3.23)
Total 307 (100) 90
a Eighteen prescriptions could not be assessed because of insufficient information
bOR odds ratio
c Narrow-spectrum penicillin: penicillin and flucloxacillin
d Penicillins with extended spectrum: amoxicillin and piperacillin
e Polymyxins: colistin
f Other: linezolid, nitrofurantoin, rifampicin, doxycycline, sulfadiazine
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prevalence of antibiotic drugs in a shorter time period than
other methods, circumventing laborious efforts of the inspec-
tion and collection of data on the wards [7, 16].
The prevalence of antibiotic use corresponds to the Dutch
point prevalence study in 32 hospitals by the Prevention of
Nosocomial Infections through Surveillance (PREZIES) net-
work, which showed that 32 % of all admitted patients (N=9,
599) received antibiotic drugs [4]. An Australian hospital-wide
point prevalence study showed 47 % inappropriate antibiotic
drug use in 199 adult patients from all wards of a tertiary hos-
pital using also the method developed by Gyssens et al. [15,
16]. In contrast to our study, in which risk factors for
inappropriate antibiotic prescribing included respiratory infec-
tions, fluoroquinolone or amoxicillin/clavulanic acid use, and
neurosurgical care, Ingram et al. found bone/joint infections,
creatinine level >120 mmol/l, carbapenem or macrolide use,
and being under the care of the aged care/rehabilitation team
to be risk factors. In a Dutch study 10 years ago in a 1,350-bed
teaching hospital including all medical specialties, inappropri-
ate antibiotic use was 37 %, with fluoroquinolone use being the
only statistically significant risk factor [7]. The higher inappro-
priate use in the other two studies may be explained by a dif-
ference in time [7], country [16], and the fact that we did not
include antibiotic drugs that were given prophylactically.
Table 3 Appropriateness of antibiotic therapy by diagnosisa
Diagnosis Number of
prescriptions
(% of total)
Number of inappropriate
prescriptions
Proportion of inappropriate
prescriptions
(95 % confidence interval)
ORb for inappropriate
prescriptions
(95 % confidence interval)
Respiratory tract infection 94 (30.6) 36 0.38 (0.29–0.48) Reference
Bacteremia 68 (22.1) 11 0.16 (0.09–0.27) 0.33 (0.15–0.72)
Intra-abdominal infection 22 (7.2) 4 0.18 (0.07–0.39) 0.36 (0.11–1.16)
Urinary tract infection 20 (6.5) 9 0.45 (0.26–0.66) 1.53 (0.55–4.22)
Skin and soft tissue infectionc 15 (4.9) 1 0.07 (0.01–0.30) 0.13 (0.02–1.0)
Fever of unknown origin 13 (4.2) 8 0.69 (0.42–0.87) 3.06 (0.86–10.90)
Otherd 75 (24.4) 21 0.40 (0.30–0.51) 0.63 (0.33–1.22)
Total 307 (100) 90
a Per antibiotic prescription on date X, 18 prescriptions could not be assessed because of insufficient information
bOR odds ratio
c Skin and soft tissue infection: erysipelas, cellulitis, hidradenitis suppurativa, panaritium, decubitus
d Other: less than ten prescriptions per diagnosis
Table 4 Appropriateness of antibiotic therapy by medical specializationa
Medical specialization Number of
prescriptions
(% of total)
Number of
inappropriate
prescriptions
Proportion of inappropriate
prescriptions
(95 % confidence interval)
ORb for inappropriate
prescriptions
(95 % confidence interval)
Lung diseases 57 (18.6) 16 0.28 (0.18–0.41) Reference
Surgery 53 (17.3) 17 0.32 (0.21–0.45) 1.25 (0.55–2.82)
Internal medicine 45 (14.7) 12 0.27 (0.16–0.41) 1.03 (0.42–2.48)
Hematology 25 (8.1) 9 0.36 (0.20–0.55) 0.49 (0.15–1.65)
Neurosurgery 18 (5.9) 8 0.44 (0.25–0.66) 2.28 (0.75–6.94)
Gastroenterology/hepatology 16 (5.2) 6 0.38 (0.18–0.61) 1.71 (0.52–5.58)
Neurology 14 (4.6) 6 0.43 (0.21–0.67) 1.92 (0.58–6.42)
Cardiology 14 (4.6) 6 0.43 (0.21–0.67) 2.20 (0.64–7.55)
Urology 12 (3.9) 2 0.17 (0.05–0.45) 0.64 (0.12–3.35)
Orthopedics 10 (3.3) 3 0.30 (0.11–0.60) 1.10 (0.25–4.78)
Thoracic surgery 10 (3.3) 2 0.20 (0.06–0.51) 1.71 (0.26–11.20)
Otherc 33 (10.7) 8 0.24 (0.13–0.41) 0.98 (0.36–2.65)
a Per antibiotic prescription on date X, 18 prescriptions could not be assessed because of insufficient information
bOR odds ratio
c Other: less than ten prescriptions per medical specialization. Medical specialization in this category: ear, nose, and throat; oncology; dermatology;
geriatrics; gynecology; radiotherapy
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Another explanation might be that in about half of the patients
in our study an infectious disease specialist or clinical microbi-
ologist was involved, probably leading to a lower rate of inap-
propriately prescribed antibiotic therapy [5, 10–12].
Inappropriate use of antibiotic drugs is an important deter-
minant in the development of antimicrobial resistance [17,
18]. For instance, in Europe, antimicrobial resistance is higher
in the south of Europe, where much more antibiotic therapy is
prescribed compared to Northern Europe [3, 19]. Our study
and others [7, 16] have shown that inappropriate use of anti-
biotic drugs is high, partly because of unjustified antibiotic
prescription [20–22]. This may be explained by insecurity
about a diagnosis of infection [23], as shown by insufficient
documented information for antibiotic use in medical records
[24]. Our study provides insight into the areas of inappropriate
antibiotic use and, thus, for areas in which interventions may
be successful. The importance of the identification of such
areas was shown in the rollout of antimicrobial stewardship
in a tertiary hospital in Toronto. Among patients meeting
stewardship criteria, a 21 % reduction in targeted antibiotic
utilization was shown, whereas no significant change was
found in all admitted patients [12].
Our study has some limitations.With the electronic surveil-
lance system we used, access to the medical records of pa-
tients on cardiac and thoracic ICUs was lacking. Since antibi-
otic use is high in ICUs, the prevalence of antibiotic use in our
hospital may have been lower than expected. However, our
results were in concordance with the antibiotic use in other
hospitals as shown by the PREZIES data [4]. Another aspect
is the inclusion of antibiotics that were prescribed on both
days. These antibiotics were included in the analysis because
the time difference of 12 days may have resulted in a change
of appropriateness of antibiotic therapy, such as, for instance,
the duration of therapy.
One of the methods to optimize antibiotic stewardship is a
clinical decision support system (CDSS) [9, 25]. Different
studies have shown that a CDSS leads to more appropriate
antibiotic treatments [26–30]. The surveillance system used
in this study has been developed to easily determine infection
rates in specialized patient populations, such as postoperative
wound infections in surgical patients [13] and will be devel-
oped further as an early warning system for nosocomial infec-
tions [14]. This system might be upgraded to an integrated
computer-assisted decision support system. However, our
study has shown that nearly 6 % of patients could not be
evaluated for appropriateness of antibiotic use due to insuffi-
cient information. This has to be taken into account when a
CDSS will be introduced.
In conclusion, our study provides insight into the appropri-
ateness of antibiotic prescriptions in a tertiary care center in
the Netherlands and identifies areas for improvement. We
used an electronic surveillance system, thereby making the
point prevalence study less time consuming and laborious. A
point prevalence study for antibiotic use can be an effective
tool to assess the effect of antibiotic stewardship either by an
AST or a CDSS.
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